Robert Scannevin
8Patents
2h-index
39Co-inventors
47Inventor score
Filing activity: Sep 21, 2007 → Sep 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10973810B2 | Methods for the treatment of neurological disorders | Physics | 6 | Active |
| US7803793B2 | Heterocyclic derived metalloprotease inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8883473B2 | Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases | Physics | 1 | Active |
| US12275723B2 | Compounds and uses thereof | Physics | 0 | Active |
| US8798939B2 | Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinases | Emerging Cross-Sectional Technologies | 0 | Active |
| US11873298B2 | Compounds and uses thereof | Physics | 0 | Active |
| US8753857B2 | Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11241417B2 | Compositions and methods for the treatment and prevention of neurological disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.